Vandetanib: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Vandetanib. Educational only — not medical advice.
Labeled uses
CAPRELSA is indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. Use CAPRELSA in patients with indolent, asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of CAPRELSA.
Source: FDA labeling via NIH DailyMed (set e5721cb8…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.